Capital expenditure increased 492.8%
Capital expenditure changed +492.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +492.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -105.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating cash flow changed -86.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -87577 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net income changed +71.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross margin changed -845 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital / assets changed -4989 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed +40.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed -101.0% from the comparable as-filed period.
Cash & equivalents changed -63.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current ratio changed -52.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current assets changed -32.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital changed -34.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +3430 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Research & development changed +122.5% from the comparable as-filed period.
SBC / revenue changed +14574 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory changed +42.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Total assets changed +37.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current liabilities changed +41.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed +66.6% from the comparable as-filed period.
Capex / revenue changed +12014 basis points from the comparable as-filed period.
Free-cash-flow margin changed -55288 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -43273 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
R&D / revenue changed +50790 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +1905 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Revenue changed -0.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross profit changed -13.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Shares outstanding changed +9.1% from the comparable as-filed period. The change ranks at the 0th percentile of 7 prior comparable changes.
Noncurrent long-term debt changed +8.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.